Orlov S. Nicole Schaeffer - 30 Jan 2025 Form 4 Insider Report for INSMED Inc (INSM)

Signature
/s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact
Issuer symbol
INSM
Transactions as of
30 Jan 2025
Net transactions value
-$5,920,816
Form type
4
Filing time
31 Jan 2025, 16:33:55 UTC
Previous filing
16 Jan 2025
Next filing
07 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSM Common Stock Options Exercise $808,000 +50,000 +52% $16.16 147,083 30 Jan 2025 Direct F1
transaction INSM Common Stock Options Exercise $562,384 +41,140 +28% $13.67 188,223 30 Jan 2025 Direct F1
transaction INSM Common Stock Sale $7,291,200 -91,140 -48% $80.00 97,083 30 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSM Stock Option (right to buy) Options Exercise $0 -50,000 -100% $0.000000 0 30 Jan 2025 Common Stock 50,000 $16.16 Direct F1, F2
transaction INSM Stock Option (right to buy) Options Exercise $0 -41,140 -100% $0.000000 0 30 Jan 2025 Common Stock 41,140 $13.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.